Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events

INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi

publication date: Nov 16, 2022
author/source: INTEGRA Biosciences AG



INTEGRA Biosciences is proud to announce that it has submitted company-wide emissions reduction targets through the Science Based Targets initiative (SBTi), with the aim of limiting global warming to 1.5 °C and achieving net zero by 2050 at the latest.

The SBTi partnership independently assesses and approves companies’ targets in line with strict criteria, helping to define and support best practices for ambitious climate action in the private sector. To join this initiative, INTEGRA has published a report summarizing the carbon footprint of its production sites and sales offices, and publicly committed to the following emissions reduction targets:-


  • A 42 % reduction in absolute greenhouse gas emissions by 2031, and a 90 % reduction by 2050.
  • To increase the annual percentage of renewable energy sources from 48 % in 2021 to 100 % by 2030.
  • A 51.6 % reduction in greenhouse gas emissions along the value chain per revenue by 2031, and a 97 % reduction by 2050.


INTEGRA has outlined a comprehensive action plan to achieve this, and proactive developments are already in place to align with a net zero future while ensuring positive impacts for the company’s employees and the communities it serves.

Ursula Leuthold, Sustainability Coordinator at INTEGRA Biosciences, commented: “INTEGRA is proud to be setting 1.5 °C-aligned science-based targets with SBTi, joining the global campaign to rapidly scale back greenhouse gas emissions. We believe that, by setting credible and independently validated emission targets, we can accelerate deep and urgent decarbonization within our business and beyond.”


About INTEGRA Biosciences

INTEGRA Biosciences is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.


Recent news from INTEGRA Biosciences


If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month


Today's Picks




Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners